R&D Partner Content Cell & Gene Therapy Pricing & Reimbursement Summit Unlocking Patient Access to Affordable Advanced Therapies
R&D Partner Content 6th Allogeneic Cell Therapies Summit Driving Potency, Efficacy & Durability of Universal Cell Therapies
R&D Partner Content The 3rd Next-Generation Conjugates Summit is back! Driving Innovation and Pioneering Novel Payload & Format Conjugate Design
R&D Partner Content 6th Treg Directed Therapies Summit Get ready for the much-anticipated return of the 6th Treg-Directed Therapies Summit! This year promises an enhanced experience wi
R&D Partner Content 4th Gene Therapy for Muscular Disorders 2024 4th Gene Therapy for Muscular Disorders Summit (April 16-18, Boston)
R&D Partner Content 5th RNA Editing Summit 2024 Pioneering RNA Editing Drugs Towards Clinical Realities
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
